Phase III study of SUN11031 for eating disorders
Latest Information Update: 24 May 2016
At a glance
- Drugs Ghrelin (Primary)
- Indications Anorexia nervosa; Eating disorders
- Focus Adverse reactions; Therapeutic Use
- Sponsors Daiichi Sankyo Company
- 24 May 2016 New trial record